XXY Stock Chart & Stats
€8.15
€0.10(0.57%)
At close: 4:00 PM EST
€8.15
€0.10(0.57%)
Day’s Range― - ―
52-Week Range€6.50 - €12.20
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€373.77M
Enterprise Value€331.14M
Total Cash (Recent Filing)€105.58M
Total Debt (Recent Filing)€2.04M
Price to Earnings (P/E)―
Beta-0.08
Next Earnings
Aug 05, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.05
Shares Outstanding32,306,484
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.81
Price to Sales (P/S)0.25
P/FCF Ratio6.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€11.59Price Target Upside42.24% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)0.08
Revenue Forecast (FY)€847.99M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA near-zero leverage profile and sizable equity provide a lasting cushion versus cyclical staffing demand. Low debt reduces refinancing and solvency risk, preserving financial flexibility for investments, working capital needs, or deal-related obligations over the next 2–6 months.
Positive Cash GenerationSustained positive operating and free cash flow despite net losses indicates operating cash conversion and working-capital discipline. This durable cash generation supports ongoing operations, short-term liabilities, and potential reinvestment or restructuring under new ownership.
Committed Take-Private SponsorA committed buyer with equity backing and no financing condition creates a structural catalyst enabling private restructuring and investment. Private ownership can allow longer-term strategy execution, platform investment (AI-enabled staffing) and reduced public reporting constraints.
Bears Say
Sustained Revenue DeclineA multi-period revenue decline of this magnitude erodes scale economics in staffing, undermines pricing leverage and client negotiation power. Persistently lower volumes reduce fixed-cost absorption and constrain the ability to restore prior profitability without structural demand recovery.
Margin Compression And Net LossesCompressing margins and a swing to material net losses indicate weakened earnings quality and pressure on profitability sustainability. Even with positive EBITDA and cash flow, lower margins limit surplus for reinvestment, make performance sensitive to wage or pricing shocks, and prolong recovery timelines.
Merger Litigation And Closing RiskActive legal challenges to the proxy and supplemental disclosures create execution risk for the take-private transaction. Delays or adverse rulings could increase costs, distract management, and prolong uncertainty for clients and staff, impeding strategic initiatives and integration planning.
Cross Country Healthcare News
XXY FAQ
What was Cross Country Healthcare’s price range in the past 12 months?
Cross Country Healthcare lowest stock price was €6.50 and its highest was €12.20 in the past 12 months.
What is Cross Country Healthcare’s market cap?
Cross Country Healthcare’s market cap is €373.77M.
When is Cross Country Healthcare’s upcoming earnings report date?
Cross Country Healthcare’s upcoming earnings report date is Aug 05, 2026 which is in 25 days.
How were Cross Country Healthcare’s earnings last quarter?
Cross Country Healthcare released its earnings results on May 07, 2026. The company reported -€0.026 earnings per share for the quarter, beating the consensus estimate of -€0.039 by €0.012.
Is Cross Country Healthcare overvalued?
According to Wall Street analysts Cross Country Healthcare’s price is currently Undervalued.
Does Cross Country Healthcare pay dividends?
Cross Country Healthcare does not currently pay dividends.
What is Cross Country Healthcare’s EPS estimate?
Cross Country Healthcare’s EPS estimate is <0.01.
How many shares outstanding does Cross Country Healthcare have?
Cross Country Healthcare has 32,306,484 shares outstanding.
What happened to Cross Country Healthcare’s price movement after its last earnings report?
Cross Country Healthcare reported an EPS of -€0.026 in its last earnings report, beating expectations of -€0.039. Following the earnings report the stock price went up 0.917%.
Which hedge fund is a major shareholder of Cross Country Healthcare?
Currently, no hedge funds are holding shares in DE:XXY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cross Country Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€11.59 (42.24% Upside)
€11.59 (42.24% Upside)
Blogger Sentiment
Bullish
DE:XXY Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.63%
12-Months-Change
Fundamentals
Return on Equity
-27.10%
Trailing 12-Months
Asset Growth
-21.72%
Trailing 12-Months
Company Description
Cross Country Healthcare
Cross Country Healthcare, Inc. is a U.S.-based provider specializing in talent management and consultative advisory services for healthcare organizations. The company operates through two main divisions: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment offers a broad range of recruitment and personnel solutions under the Cross Country brand. This includes both temporary and direct-hire placements for travel nurses, local nurses, and various allied health professionals. It sources registered nurses, licensed practical nurses, certified nurse assistants, practitioners, and pharmacists for per diem or short-term engagements, as well as clinical and non-clinical specialists for longer contract durations. Additionally, this segment delivers comprehensive workforce solutions, including Managed Service Programs (MSP), Recruitment Process Outsourcing (RPO), and consulting, alongside retained and contingent search services for healthcare professionals. Its diverse clientele spans public and private hospitals (both acute and non-acute care), government facilities, national and local healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care centers, and physician practice groups. The Physician Staffing segment, operating as Cross Country Locums, focuses on supplying independent contractor physicians across numerous specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners, and physician assistants. These professionals are deployed on temporary assignments to various healthcare environments, such as acute and non-acute care facilities, medical group practices, government establishments, and managed care organizations. Cross Country Healthcare, Inc. was established in 1986 and is headquartered in Boca Raton, Florida.
XXY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a balanced picture: the company reported significant revenue declines and a large noncash impairment that pressured profitability in 2025, but it also emphasized a strong balance sheet (no debt, $109M cash), meaningful cost reductions, accelerating weekly production and strategic investments in proprietary technology (Intellify/Xperience) and AI. Management provided cautious near-term guidance (Q1 revenue $235M–$240M; adjusted EBITDA ~$4M–$5M) while outlining a credible path to recovery — targeting a >$1B revenue run-rate and 4%–5% adjusted EBITDA margin by year-end 2026 — backed by redeployed cost savings, headcount optimization, and growth in higher-margin segments (home-based and education). Given the material past declines and impairment but clear remediation plans, the tone is cautiously optimistic with balanced risks and opportunities.View all DE:XXY earnings summariesXXY Stock 12 Month Forecast
Average Price Target
€11.59
▲(42.24% Upside)
Technical Analysis
AMN Healthcare Services
―
Community Health
―
Astrana Health
―
InnovAge Holding
―
Agilon Health
―
Options Prices
Currently, No data available
---